Free shipping on all orders over $ 500

Pyroxamide

Cat. No. M3243

All AbMole products are for research use only, cannot be used for human consumption.

Pyroxamide Structure
Synonym:

NSC-696085

Size Price Availability Quantity
5mg USD 55 In stock
10mg USD 95 In stock
25mg USD 200 In stock
50mg USD 330 In stock
100mg USD 550 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Pyroxamide (NSC 696085) is a potent histone deacetylase inhibitor with an IC50 of 100 nM for HDAC-1. In a study, administration of pyroxamide (100 or 200 mg/kg/day) to nude mice at doses that caused little evident toxicity significantly suppressed the growth of s.c. CWR22 prostate cancer xenografts. Despite the potent growth-inhibitory effects of pyroxamide in this tumor model, serum prostate-specific antigen levels in control versus pyroxamide-treated mice were not significantly different. It causes the accumulation of acetylated core histones in MEL cells cultured with the agent. Human CWR22 prostate tumor xenografts from mice treated with pyroxamide (100 or 200 mg/kg/day) showed increased levels of histone acetylation and increased expression of the cell cycle regulator p21/WAF1, compared with tumors from vehicle-treated control animals.

Chemical Information
Molecular Weight 265.31
Formula C13H19N3O3
CAS Number 382180-17-8
Solubility (25°C) DMSO
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Jakob Haldrup, et al. FRMD6 has tumor suppressor functions in prostate cancer

[2] Gregory Kouraklis, et al. Histone deacetylase inhibitors: a novel target of anticancer therapy (review)

[3] Martha C Kutko, et al. Histone deacetylase inhibitors induce growth suppression and cell death in human rhabdomyosarcoma in vitro

[4] G Kouraklis, et al. Histone deacetylase inhibitors and anticancer therapy

[5] L M Butler, et al. Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase

Related HDAC Products
Belinostat

Belinostat (PXD101) is a novel HDAC inhibitor with an IC50 of 27 nM.

CUDC-101

CUDC-101 is a potent multitargeted HDAC, EGFR and HER2 inhibitor with IC50 of 4.4, 2.4, and 15.7 nM, respectively.

Givinostat hydrochloride monohydrate

ITF2357 (Givinostat, Gavinostat) is a histone deacetylase inhibitor. The IC50 values for maize HDAC preparations HD2, HD-1B and HD-1A are 10, 7.5 and 16 nM respectively.

Niltubacin

Niltubacin, as an inactive derivative of Tubacin, is a highly potent and selective, reversible cell-permeable inhibitor of HDAC6.

Tubacin

Tubacin (Tubulin Acetylation Inducer) is a highly potent and selective, reversible cell-permeable inhibitor of HDAC6 with IC50 of 0.004µM.

  Catalog
Abmole Inhibitor Catalog




Keywords: Pyroxamide, NSC-696085 supplier, HDAC, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.